MES2030

N/A

Report date: 2024/08/21 10:38:46
NME

Base Information

Drug NameMES2030
Drug Alias NameMES2030MES-2030
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP4 receptor agonists
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsPulmonary FibrosisPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMesentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesMesentech Inc
Inactive CompaniesN/A
Active IndicationsPulmonary FibrosisPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A